124 related articles for article (PubMed ID: 12825098)
1. Evaluating dose regimens of apomorphine, an open-label study.
Kongkanand A; Opanuraks J; Tantiwongse K; Choeypunt N; Tantiwong A; Amornvejsukit T
Int J Impot Res; 2003 Apr; 15 Suppl 2():S10-2. PubMed ID: 12825098
[TBL] [Abstract][Full Text] [Related]
2. Tolerability and safety of apomorphine SL (Ixense (TM) ).
Montorsi F
Int J Impot Res; 2003 Apr; 15 Suppl 2():S7-9. PubMed ID: 12825097
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men.
Gontero P; D'Antonio R; Pretti G; Fontana F; Panella M; Kocjancic E; Allochis G; Frea B
Int J Impot Res; 2005; 17(1):80-5. PubMed ID: 15510184
[TBL] [Abstract][Full Text] [Related]
4. An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction.
Mulhall JP; Bukofzer S; Edmonds AL; George M;
Clin Ther; 2001 Aug; 23(8):1260-71. PubMed ID: 11558862
[TBL] [Abstract][Full Text] [Related]
5. A European multicentre study to evaluate the tolerability of apomorphine sublingual administered in a forced dose-escalation regimen in patients with erectile dysfunction.
Von Keitz AT; Ströberg P; Bukofzer S; Mallard N; Hibberd M
BJU Int; 2002 Mar; 89(4):409-15. PubMed ID: 11872034
[TBL] [Abstract][Full Text] [Related]
6. A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction.
Perimenis P; Gyftopoulos K; Giannitsas K; Markou SA; Tsota I; Chrysanthopoulou A; Athanasopoulos A; Barbalias G
Int J Impot Res; 2004 Feb; 16(1):2-7. PubMed ID: 14963464
[TBL] [Abstract][Full Text] [Related]
7. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
Eardley I; Wright P; MacDonagh R; Hole J; Edwards A
BJU Int; 2004 Jun; 93(9):1271-5. PubMed ID: 15180621
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of apomorphine SL (Uprima).
Bukofzer S; Livesey N
Int J Impot Res; 2001 Aug; 13 Suppl 3():S40-4. PubMed ID: 11477491
[TBL] [Abstract][Full Text] [Related]
9. An open-label, randomized, flexible-dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men with erectile dysfunction.
Giammusso B; Colpi GM; Cormio L; Ludovico G; Soli M; Ponchietti R; Montorsi F; Panzironi C; Guastella B
Urol Int; 2008; 81(4):409-15. PubMed ID: 19077401
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of fixed-dose and dose-optimization regimens of sublingual apomorphine versus placebo in men with erectile dysfunction. The Apomorphine Study Group.
Dula E; Keating W; Siami PF; Edmonds A; O'neil J; Buttler S
Urology; 2000 Jul; 56(1):130-5. PubMed ID: 10869641
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
12. Vardenafil improved patient satisfaction with erectile hardness, orgasmic function and sexual experience in men with erectile dysfunction following nerve sparing radical prostatectomy.
Nehra A; Grantmyre J; Nadel A; Thibonnier M; Brock G
J Urol; 2005 Jun; 173(6):2067-71. PubMed ID: 15879836
[TBL] [Abstract][Full Text] [Related]
13. Oral treatment of erectile dysfunction with apomorphine SL.
Altwein JE; Keuler FU
Urol Int; 2001; 67(4):257-63. PubMed ID: 11741126
[TBL] [Abstract][Full Text] [Related]
14. Inhalation device allows novel administration of apomorphine in men with erectile dysfunction-efficacy and safety findings.
Riley A; Main M; Morgan F
J Sex Med; 2010 Apr; 7(4 Pt 1):1508-17. PubMed ID: 19845547
[TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder.
Caruso S; Agnello C; Intelisano G; Farina M; Di Mari L; Cianci A
Urology; 2004 May; 63(5):955-9. PubMed ID: 15134988
[TBL] [Abstract][Full Text] [Related]
16. Comparative trial of treatment satisfaction, efficacy and tolerability of sildenafil versus apomorphine in erectile dysfunction--an open, randomized cross-over study with flexible dosing.
Porst H; Behre HM; Jungwirth A; Burkart M
Eur J Med Res; 2007 Feb; 12(2):61-7. PubMed ID: 17369119
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction.
Dula E; Bukofzer S; Perdok R; George M;
Eur Urol; 2001 May; 39(5):558-3; discussion 564. PubMed ID: 11464037
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of daily intake of apomorphine SL in men affected by erectile dysfunction and mild hyperprolactinemia: a prospective, open-label, pilot study.
Caruso S; Intelisano G; Farina M; DiMari L; Agnello C; Giammusso B
Urology; 2003 Nov; 62(5):922-7. PubMed ID: 14624921
[TBL] [Abstract][Full Text] [Related]
19. Comparative cross-over study of sildenafil and apomorphine for treating erectile dysfunction.
Afif-Abdo J; Teloken C; Damião R; Koff W; Wroclawski E; Yamasaki R; Torres LO; Sabaneeff J; Faria G; Pompeo AC; Cortado P; Glina S
BJU Int; 2008 Sep; 102(7):829-34. PubMed ID: 18537952
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction.
Kirby RS; O'Leary MP; Carson C
BJU Int; 2005 Jan; 95(1):103-9; discussion 109. PubMed ID: 15638905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
